With shares of Lockheed Martin (NYSE:LMT) trading around $129, is LMT an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementLockheed Martin is a global security and aerospace company principally engaged in the research, design, development, manufacture, integration, and sustainment of technology systems and products. The company also provides a range of management, engineering, technical, scientific, logistic, and information services. It serves both domestic and international customers with products and services that have defense, civil, and commercial applications with its principal customers being agencies of the U.S. government. It operates in five business segments: Aeronautics, Information Systems & Global Solutions, Missiles and Fire Control, Mission Systems and Training, and Space Systems.
Lockheed Martin is cutting 600 jobs around the country from its Washington, D.C.-based Mission Systems and Training Division this month, the Washington Post reports. Lockheed Martin said the job cuts were not caused by the government shutdown but by increased competition and uncertainty over funding, according to a company spokesman. Lockheed Martin�� Mission Systems and Training unit focuses on making drones and other unmanned technologies.
5 Best Chemical Stocks To Own Right Now: Elite Pharmaceuticals Inc (ELTP)
Elite Pharmaceuticals, Inc. (Elite), incorporated on October 1, 1997, is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals. Elite has four products: Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules and Hydromorphone Hydrochloride 8 milligram tablets. During the fiscal years ended March 31, 2012 (Fiscal 2011), the Company manufactured and sold Lodrane 24 and Lodrane 24D (the Lodrane Extended Release Products).
The Company has a pipeline of additional generic drug candidates under active development, including, without limitation, ELI-154, a once-a-day oxycodone product and ELI-216, an abuse resistant oxycodone product which utilizes the Company�� propriety formulation for abuse resistant products utilizing the pharmacological approach (Elite�� Abuse Resistant Technology). ECR Pharmaceuticals (ECR), a wholly owned subsidiary of Hi-Tech Pharmacal, Inc. and the owner and marketer of the Lodrane Extended Release Products. Elite also purchased from Mikah Pharma LLC, an approved Abbreviated New Drug Application (ANDA) for Naltrexone 50 milligram tablets.
For ELI-154, Elite has developed a once-daily oxycodone formulation using its technology. An investigational new drug application (IND) has been filed and Elite has completed two pharmacokinetic studies in healthy subjects that compared blood levels of oxycodone from dosing ELI-154 and the twice-a-day product that is on the market, OxyContin marketed in the United States by Purdue Pharma LP. ELI-216 utilizes the Company's abuse-deterrent technology that is based on a pharmacological approach. ELI-216 is a combination of a narcotic agonist, oxycodone hydrochloride, in a sustained-release formulation intended for use in patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulat! ed to deter abuse of the drug. Products utilizing the pharmacological approach to deter abuse such as Suboxone, a product marketed in the United States by Reckitt Benckiser Pharmaceuticals, Inc., and Embeda, a product marketed in the United States by Pfizer, have been approved by the United States Food & Drug Administration (FDA). ELI-216 demonstrates a euphoria-blocking effect when the product is crushed. Elite has developed ELI-154 and ELI-216 and retains the rights to these products.
The Company competes with Collegium Pharmaceuticals, Inc., Purdue Pharma LP, Acura Pharmaceuticals, Inc., Durect Corporation, Mylan Laboratories, Inc., Par Pharmaceuticals, Inc., Alkermes, Inc., Teva Pharmaceuticals Industries Ltd., Aptalis Pharma, Impax Laboratories, Inc., and Watson Pharmaceuticals.
Advisors' Opinion:- [By CRWE]
Today, ELTP has shed (-8.01%) down -0.009 at $.101 with 4,629,899 shares in play thus far (ref. google finance Delayed: 1:00PM EDT September 16, 2013).
Elite Pharmaceuticals, Inc. previously reported the first quarter of fiscal year 2014 ended June 30, 2013. Manufacturing and profit split revenues comprised almost all of Elite’s quarterly revenues and totaled $717k for the quarter, an increase of 41% from the prior year. This growth is attributed to the launch of two new products during the quarter, Phentermine 15mg and 30mg capsules, combined with strong year-on-year growth of the Elite’s Hydromorphone 8mg tablets and contract manufactured Methadone 10mg product lines.
- [By James E. Brumley]
Exactly one month ago today I penned some bullish thoughts on Elite Pharmaceuticals Inc. (OTCBB:ELTP). If you're familiar with the company - or a regular reader of this site - then you may know why that sounds a little "off." See, at the time, ELTP shares were falling rather quickly, giving up all the gains they had made just a few days before. Almost needless to say, my premise was not a well received one. Let's just say I received some "colorful disagreements" by being optimistic about the biopharma company.
- [By James E. Brumley]
Judging from the company it's keeping Green Automotive Co. (OTCMKTS:GACR) may have just made its way into the upper echelon of small cap stock opportunities. The electric car company joins Elite Pharmaceuticals Inc. (OTCBB:ELTP), Amarantus Bioscience Holdings, Inc. (OTCBB:AMBS), and only three other companies as Wall-Street.com's "Best 6 Stocks" for January of 2014. As one of the top information resources for investors - particularly in terms of information regarding small and micro cap stocks - being named among the site's top pick is an accolade for AMBS, ELTP, and GACR. Even more impressive is that Green Automotive Co. was the only consumer-goods name among those six. Amarantus Bioscience Holdings and Elite Pharmaceuticals are biotechnology names... an industry that can and often does attract a lot of attention just by the nature of the business. The other three names making the "Best 6" list were an energy explorer, a power-management technology manufacturer, and prescription/medical food producer. For an electric car manufacturer to make the list speaks quite highly of GACR.
Best Tech Stocks To Watch For 2014: AXT Inc(AXTI)
AXT, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes compound and single element semiconductor substrates for use in wireless communications, lighting display applications, fiber optic communications, and solar cell. It offers semi-insulating substrates made from gallium arsenide, which are used in power amplifiers and radio frequency integrated circuits of wireless handsets, direct broadcast televisions, high-performance transistors, and satellite communications applications. The company also provides semi-conducting substrates made from gallium arsenide that are used for applications in light emitting diodes, lasers, and optical couplers; substrates made from indium phosphide used in broadband and fiber optic communications; and substrates made from germanium used in satellite and terrestrial solar cells, and for optical applications. It manufactures its semiconductor substrates using its proprietary vertical gradient freeze technol ogy. In addition, the company, through its joint venture agreements, manufactures and sells gallium, arsenic, germanium, germanium dioxide, paralytic boron nitride crucibles, and boron oxide. AXT, Inc. sells its products through direct sales force in the United States, as well as through independent sales representatives in France, Germany, Japan, South Korea, Taiwan, and the United Kingdom. The company was formerly known as American Xtal Technology, Inc. and changed its name to AXT, Inc. in July 2000. AXT, Inc. was founded in 1986 and is headquartered in Fremont, California.
Advisors' Opinion:- [By Eric Volkman]
SciClone (NASDAQ: SCLN ) has a new man leading its finance team. The company announced that it hired Wilson Cheung to be its new CFO. Cheung is a longtime executive who most recently served as chief compliance officer, Asia Pacific, at digital marketing agency Velti, following a stint as that company's CFO. Before that, he was CFO and corporate secretary at AXT (NASDAQ: AXTI ) and served in various managerial positions in firms such as KPMG and Yahoo!
Best Tech Stocks To Watch For 2014: Thermo Fisher Scientific Inc(TMO)
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Its Analytical Technologies segment offers analytical instruments to analyze prepared samples, software interpretation tools, laboratory information management systems, and laboratory automation systems; environmental instruments and integrated systems for environmental monitoring, safety, and security applications; and process instruments, integrated systems, and measurement solutions. It also provides diagnostics products used in healthcare laboratories to prepare and analyze patient samples; and biosciences products comprising reagents and consumables used in life science research, drug discovery, and biopharmaceutical production. The company?s Laboratory Products and Services segment offers laboratory equipment, including sample preparation, environment storage and handling equipment, and laboratory workstations; laboratory consumables; research market solutions consisting of chemicals, instruments and apparatus, liquid handling pumps and devices, and capital equipment and consumables; and healthcare market products comprising analytical equipment, diagnostic tools, and reagents and consumables. It also provides workplace and first responder equipment, protective gear, and apparel; and packaging, warehousing, distribution, labeling, pharmaceutical and biospecimen storage, and analytical laboratory services in the area of drug discovery and pharmaceutical clinical trials. The company serves pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial process control settings primarily in the United States, Germany, and the United Kingdom. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Rich Smith]
Thermo Fisher Scientific (NYSE: TMO ) snagged a sizable equipment contract from the Department of Defense Monday. In its daily list of contract award announcements, the DoD confirmed that it has reupped a fixed-price with economic-price-adjustment supply agreement with TFS subsidiary Fisher Scientific for a fourth and final option year, ending May 3, 2014.
- [By Rich Smith]
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines include upgrades for both Thermo Fisher Scientific (NYSE: TMO ) and DreamWorks (NASDAQ: DWA ) . But it's not all good news. Turns out, despite projections of 43% revenue growth in Q1, one analyst is busy ...
- [By Monica Gerson]
Thermo Fisher Scientific (NYSE: TMO) is estimated to report its Q3 earnings at $1.28 per share on revenue of $3.18 billion.
General Dynamics (NYSE: GD) is expected to report its Q3 earnings at $1.68 per share on revenue of $7.76 billion.
Best Tech Stocks To Watch For 2014: Textura Corp (TXTR)
Textura Corporation, incorporated on September 27, 2007, is a provider of on-demand business collaboration software to the commercial construction industry. The Company�� solutions are focused on facilitating collaboration between owners/developers, general contractors and subcontractors. The Company offers PlanSwift, a take-off and estimating solution used in preparing construction bids, and Contractor Default Claims Management, which supports the process of documenting a subcontractor default insurance claim. Each of its collaboration solutions was designed from inception as a software-as-a-service (SaaS) solution with on-demand architecture. The Company collaboration solutions each use a single code base and it do not customize its solutions for any of the Company�� clients. In December 2013, Textura Corp closed its acquisition of LATISTA Technologies Inc, the provider of mobile-enabled solutions for construction project collaboration.
The Company�� collaboration solutions offer functionality, data sharing and exchange capabilities, and workflow tools that support several business processes at various stages of the construction project lifecycle, which include Construction Payment Management (CPM) enables the generation, collection, review and routing of invoices and the necessary supporting documentation and legal documents, and initiation of payment of invoices; Submittal Exchange enables the collection, review and routing of project documents; GradeBeam supports the process of obtaining construction bids, including identifying potential bidders, issuing invitations-to-bid and tracking bidding intent; Pre-Qualification Management (PQM) supports contractor risk assessment and qualification, and Greengrade facilitates the management of environmental certification processes. The Company�� on-demand business collaboration software solutions address the several challenges associated with the traditional paper-based and personnel-intensive manual approaches or with technology solut! ions not designed for collaborative processes, and support many of the trends occurring within the commercial construction industry.
Advisors' Opinion:- [By Dan Caplinger]
It took four days, but Dow 16,000 finally stuck until the close, with the Dow Jones Industrials (DJINDICES: ^DJI ) finishing the day up 109 points. Particularly strong showings from the financial contingent of the Dow 30 pushed the average up, but their gains were small compared to the larger jumps that Sprint (NYSE: S ) , Textura (NYSE: TXTR ) , and Williams-Sonoma (NYSE: WSM ) saw. Let's look at why these three companies did so well today, to see if we can draw hints about other potential winners down the road.
- [By David Zeiler]
6. Textura Corp. (NYSE: TXTR): Textura creates and sells business collaboration software to the commercial construction industry. TXTR went public June 7 at $15 a share and rose 39.6% its first day. The stock currently trades at $40.080, for an increase of 167.2%.
- [By Jake L'Ecuyer]
Textura (NYSE: TXTR) tumbled 6.15 percent to $29.38. Textura shares tumbled 17.06 percent yesterday after Citron Research issued a scathing report on the company midway through the morning Thursday.�
No comments:
Post a Comment